| Trial name or title |
Clinical Trial of the Effects of DHA in the Treatment of Seizure Disorders |
| Methods |
Randomised, double‐blind, placebo controlled |
| Participants |
Male or female, aged 15 years or older, three or more seizures per month |
| Interventions |
Daily dose of fish oil standardized to contain 3 g/day of DHA. The daily dose is divided; capsules are taken with meals for a period of 6 months |
| Outcomes |
Seizure diary, serum polyunsaturated fatty acid levels, serum anticonvulsant levels, adverse reactions |
| Starting date |
January 2013 |
| Contact information |
Miles Thomson, PhD (epilepsypufastudy@gmail.com) |
| Notes |
http://ClinicalTrials.gov/show/NCT01769092
|
